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Abstract: 
Fecal water is a complex mixture of various metabolites with a wide range of physicochemical 
properties and boiling points. The analytical method developed here provides a qualitative and 
quantitative gas chromatography/mass spectrometry (GC/MS) analysis, with high sensitivity and 
efficiency, coupled with derivatization of ethyl chloroformate in aqueous medium. The 
water/ethanol/pyridine ratio was optimized to 12:6:1, and a two-step derivatization with an initial 
pH regulation of 0.1 M sodium bicarbonate was developed. The deionized water exhibited better 
extraction efficiency for fecal water compounds than did acidified and alkalized water. 
Furthermore, more amino acids were extracted from frozen fecal samples than from fresh 
samples based on multivariate statistical analysis and univariate statistical validation on GC/MS 
data. Method validation by 34 reference standards and fecal water samples showed a correlation 
coefficient higher than 0.99 for each of the standards, and the limit of detection (LOD) was from 
10 to 500 pg on-column for most of the standards. The analytical equipment exhibited excellent 
repeatability, with the relative standard deviation (RSD) lower than 4% for standards and lower 
than 7% for fecal water. The derivatization method also demonstrated good repeatability, with 
the RSD lower than 6.4% for standards (except 3,4-dihydroxyphenylacetic acid) and lower than 
10% for fecal water (except dicarboxylic acids). The qualitative means by searching the electron 
impact (EI) mass spectral database, chemical ionization (CI) mass spectra validation, and 
reference standards comparison totally identified and structurally confirmed 73 compounds, and 
the fecal water compounds of healthy humans were also quantified. This protocol shows a 
promising application in metabolome analysis based on human fecal water samples. 
 
Article: 
Humans are considered to be complex “superorganisms” because of the magnitude of symbiotic 
gut microflora [1]. The human colon constitutes an ecologically complicated microbiota 
community with more than 500 bacterial species and an aggregate biomass of 100 trillion [2]. 
Plant-derived foods contain a multiplicity of bioactive phytochemicals, such as dietary fibers and 
polyphenols, which pass indigestibly through the gut and are readily degraded into various 
biologically active compounds by the resident gut microbiota in the colon [3-5]. These 
metabolites and their active derivatives, such as short-chain fatty acids, phenolic acids, and 
vitamins, modulate human nutrition and health by decreasing risk of developing gastrointestinal 
disorder [6], cancer [7], diabetes [8], and cardiovascular disease [9]. Recent research shows that 
human symbiotic gut microbiota modulate the variation of human metabolic phenotypes in fecal 
and urinary samples [10]. Thus, metabolite compositions and variations of feces not only reflect 
the status of the gut microbiome community but also bridge the relationships between symbiotic 
microbes and the host’s (human) health. There is general consensus that the aqueous phase of 
human feces, fecal water, directly interacts with the colonic epithelium, and its composition and 
concentration appears to be an important factor for a healthy colon environment [11,12]. Today, 
fecal water has been a common medium in human nutrition and health studies. 
 
Characterizing the metabolite profile of human fecal water requires a holistic metabolite 
analysis. Metabonomics is “the quantitative measurement of the multiparametric metabolic 
responses of a living system to pathophysiological stimuli or genetic modification,” as described 
by Nicholson and coworkers [13]. Combining a robust instrumental analysis method with 
holistically extracted metabolite information and multivariate statistical analysis, such as 
principal component analysis (PCA)1 and partial least squares discriminant analysis (PLS–DA) 
[14], metabonomics is an efficient means to elucidate significant differences and screen the 
potential “biomarkers” account for such variance within majorities of metabolites. However, a 
comprehensive metabolite analysis is difficult to achieve due to the wide range of structural 
diversity of compounds in human fecal water. Potential analytical methods include nuclear 
magnetic resonance (NMR) spectroscopy, mass spectrometry (MS) techniques based on high-
performance liquid chromatography (LC), capillary electrophoresis (CE), and gas 
chromatography (GC). 
 
NMR is a global and nondestructive technique requiring minimal sample pretreatment, and the 
comprehensive metabolite analysis of fecal water based on NMR has been attempted [15-17]. 
GC/MS was shown to be a robust method for quantification of selected metabolites, with more 
satisfactory sensitivity and resolution than the conventional NMR approach and better reliability 
in structure identification of candidate biomarkers than LC/MS [18], and was applied in 
metabonomic research of urinary and serum samples and brain tissue extracts [19-22]. In 
addition, mass spectral databases, such as NIST05, Wiley, and “Agilent Fiehn GC/MS 
Metabolomics RTL Library” (commercially available), further facilitated the identification of 
metabolites. In spite of such advantages, the GC/MS method hitherto concerned the analysis of 
only a certain class of metabolites such as fatty acids or phenolic acids in fecal water [23,24]. To 
date, simultaneous analysis of multiple classes of human fecal compositions with varied 
physicochemical properties has not been reported. 
 
For comprehensive metabolome analysis based on GC/MS, derivatization is an effective method 
of rendering highly polar materials sufficiently volatile and narrowing the boiling point window 
so that they can be eluted at reasonable temperatures without thermal decomposition or 
molecular rearrangement. Derivatization also improves compound ionization. The active 
functional groups, such as carboxylic, amide, amino, and hydroxyl groups, are either alkylated, 
acylated, or silylated [25,26]. The silylation derivatization procedure needs a nonaqueous 
environment for the reaction, whereas some nonsilylating derivatization techniques, such as 
chloroformate derivatization, can be performed in the presence of water. Chloroformates have 
been proven to be strong and rapid derivatizing reagents, and in contrast to trimethylsilylation 
(TMS) derivatization, alkyl chloroformate derivatization reactions occurred directly in aqueous 
media without the requirement of heating, thereby simplifying the sample pretreatment and 
derivatization procedure and consequently improving the batch repeatability [27,28]. Recent 
work indicates that the revised ethyl chloroformate (ECF) derivatization procedure can be well 
applied in holistically analyzing the metabolites of urinary and serum samples [20,21]. In the 
current study, we attempted the GC/MS analysis method coupled with chloroformate 
derivatization to describe the metabolome of human fecal water. The derivatization parameters 
and the pH of extraction solvent were studied emphatically in terms of relative derivatization 
efficiency and multivariate statistical analysis, respectively. Such a method was validated by 
different categories of 34 standards as well as by fecal water samples. More than 70 metabolites 
were identified and structurally confirmed by comparing with standards, searching database 
libraries, and making structural identifications based on mass spectral data of electron impact 
(EI) and chemical ionization (CI). 
 
MATERIALS AND METHODS 
Chemicals and materials 
ECF, pyridine, and sodium hydroxide (NaOH) from Fluka (Saint Quentin en Yvelines, France) 
and anhydrous ethanol and n-hexane from Riedel-de Haën (Seelze, Germany) were used for 
derivatization reagents. l-2-Chloro-phenylalanine (a Sigma product) was used as an internal 
standard (IS) for batch quality control. Sodium bicarbonate and sodium sulfate were analytical 
reagent grade. All standards (Table 1), which were commercially obtained from Sigma–Aldrich 
(St. Louis, MO, USA), were prepared in ultrapure water (Milli-Q system, Millipore, Billerica, 
MA, USA) or ethanol solution (Riedel-de Haën). Human fecal water samples were prepared as 
follows: the homogenized stool samples (5–8 g) were ultracentrifuged at 4 °C and 50,000 rpm 
(equivalent to 171,500g average on Ti rotor angular 70.1 Beckman) for 2 h, and 2 μl of NaN3 
(100 mg ml−1) as an antimicrobial agent per gram of fecal water was added to the supernatants, 
which were stored at −80 °C as 1-ml fecal water aliquots prior to the derivatization. 
 
Effects of extraction solvents on human feces metabolome 
Three kinds of extraction solvents—pure water, formic acid (0.2 M), and NaOH aqueous 
solution (0.15 M)—were selected to evaluate extraction effects on metabolome of human feces. 
The homogenized cold feces (1 g) was mixed with 1 ml of extraction solvent (4 °C), vortexed for 
30 s, ultrasonicated for 2 min (4 °C), and vortexed for 30 s prior to ultracentrifugation 
(171,500g) for 30 min at 4 °C. A 1-ml aliquot of supernatant was collected for a diluted fecal 
water sample. To eliminate the effects of pH differences between fecal water samples on 
derivatization efficiency, all diluted fecal water samples were further adjusted isometrically to 
the same pH value as that extracted by deionized water using NaOH or formic acid aqueous 
solution before derivatization. 
 
Effects of frozen storage of feces on recovery of fecal water compounds 
Fecal water was extracted from either fresh or frozen–thawed aliquots of the same six stool 
specimens (from six healthy individuals). The frozen aliquots had been stored at −80 °C for 
3 months. Each fecal water sample was derivatized in triplicate, and its derivatives in n-hexane 
were analyzed by GC/MS. 
Table 1: Effects of initial pH regulation on relative derivatization efficiencies of test compounds 
in contrast to control two-step derivatization. 
Compound Formic acid (mol L−1)  Sodium bicarbonate (mol L−1) 
0.01 0.1  0.1 1.0 
Monocarboxylic acids      
2-Methylbutyric acid −2.89 −21.53  4.19 −21.90 
Hexanoic acid 0.08 −4.80  2.33 4.66 
Nonanoic acid −2.40 3.07  6.10 3.70 
Myristic acid 0.49 0.10  9.77 15.51 
Oleic acid −0.94 −3.98  4.03 8.32 
Stearic acid −2.87 −10.69  8.56 20.18 
      
Dicarboxylic acids      
Succinic acid −12.91 −14.82  −1.64 −58.54 
Methylsuccinic acid −14.96 −24.89  −5.02 −53.27 
Glutaric acid −9.03 −14.81  −3.71 −41.86 
Malic acid −9.43 −42.07  12.42 −55.14 
Suberic acid 0.77 7.03  8.58 0.15 
Sebecic acid 2.97 1.56  3.91 5.75 
      
Phenolics      
Benzoic acid −9.52 −27.65  −5.45 −61.32 
Phenylacetic acid −0.79 3.87  0.17 −5.38 
3-Phenylpropionic acid 0.04 3.29  3.63 4.26 
4-Hydroxybenzoic acid −3.68 −23.02  −1.37 −64.18 
4-Hydroxyphenylacetic acid −0.90 −1.76  6.11 −12.83 
3,4-Dihydroxyphenylacetic acid 1.47 7.44  2.25 −36.54 
      
Amino acids      
Alanine −12.51 −68.98  4.51 −64.04 
Valine −9.63 −63.77  1.04 −58.86 
Leucine −12.72 −66.17  5.04 −38.72 
Proline −2.99 −39.35  1.05 −62.57 
Phenylalanine −12.73 −59.26  8.08 −49.92 
Tyrosine −10.31 −66.19  10.62 −69.23 
Note. The increases (%) of relative derivatization efficiency compared with control two-step derivatization were calculated by the following 
formula: 100∗ (peak area of two-step derivatization with pH regulation − peak area of control two-step derivatization)/peak area of control two-
step derivatization. 
 
Sample derivatization 
In the first step of derivatization reaction, 100 μl of l-2-chloro-phenylalanine (0.1 mg ml−1 in 
0.6 M NaHCO3), 350 μl of ethanol/pyridine (6:1), and 50 μl of ECF were added to each 500-μl 
aliquot of diluted fecal water sample or the mixture of the 34 test standards in a Corning 
disposable glass centrifuge tube with a screw cap. The reaction mixture was then vortexed for 
10 s and ultrasonicated for 60 s to accelerate the reaction at room temperature. The derivatization 
products were vortexed with 400 μl of n-hexane for 30 s and centrifuged for 5 min at 3000 rpm. 
Then 100 μl of NaOH (7 M) was added to the aqueous layer to adjust the pH to 9 to 10, followed 
by an additional 50 μl of ECF to trigger the second step of the derivatization procedure. The 
derivatization mixture was vortexed for 10 s, ultrasonicated for 60 s, and again vortexed for 30 s 
prior to centrifugation at 3000 rpm for 10 min. 
 
To compare the relative derivatization efficiency caused by varying derivatization parameters, 
100 μl of 200 μg ml−1 ethyl 3-(methylthio)propionate (EMP, in n-hexane) was added into the 
derivatization medium before the last vortex. A total of 350 μl of derivatives (organic layer) was 
transferred to a small crimp top glass vial with anhydrous granular sodium sulfate to remove 
traces of water. The anhydrous derivatives in n-hexane were subjected to GC/MS assay. The 
procedure for preparing ECF derivatives of fecal water is illustrated in Fig. 1. 
 
Figure 1: Procedure for preparing ECF derivatives of fecal water. 
 
 
 
 
GC/MS analysis conditions 
Each 1-μl aliquot of the derivatives was injected in a splitless mode into an Agilent 7890A GC 
system coupled to an Agilent 5975C inert XL EI/CI mass spectrometric detector (MSD) system 
(Agilent Technologies, Santa Clara, CA, USA). An HP-5MS capillary column coated with 5% 
phenyl/95% methylpolysiloxane (30 m × 250 μm i.d., 0.25 μm film thickness, Agilent J & W 
Scientific, Folsom, CA, USA) was used to separate the derivatives. The initial oven temperature 
was held at 40 °C for 3 min; ramped to 60 °C at a rate of 10 °C min−1, to 140 °C at a rate of 
8 °C min−1, to 240 °C at a rate of 5 °C min−1, and to 280 °C at a rate of 20 °C min−1; and finally 
held at 280 °C for 3 min. Helium was used as a carrier gas at a constant flow rate of 1 ml min−1 
through the column. The initial inlet gas pressure was 7.069 psi. The temperatures of the EI ion 
source and injector were 200 and 280 °C, respectively. The electron energy was 70 eV, and mass 
data were collected in a full-scan mode (m/z 30–550). The solvent delay was set at 5 min. 
Agilent “retention time locking” (RTL) was applied to control the accuracy of retention time 
(RT), where phenylalanine was selected as the calibrated compound. For CI mode, the same 
capillary column and GC parameters were set. Pure methane was used as reagent gas. 
 
Method validation 
A total of 34 standard mixture and fecal water samples were used to validate the developed 
method. Each stock solution of test standard was carefully prepared in the deionized water 
(2 mg ml−1) or pure ethanol (2 mg ml−1) and stored at −20 °C. The spiked standard solution was 
obtained accordingly by adding 500 μl of each aliquot of stock solution to water or ethanol, 
respectively, to obtain 50 μg ml−1 of the spiked standard solution. The spiked standard solution 
was diluted in water or ethanol, and then two types of spiked standard solutions with the same 
concentration were combined into different concentrations of spiked standard solution in 50% 
ethanol for the determination of linear range, regression coefficient (R2), limit of detection 
(LOD), and repeatability. 
 
Extraction and pretreatment of GC/MS raw data 
Raw GC/MS data were converted into CDF format (NetCDF) files by Agilent GC/MS 5975 Data 
Analysis software and subsequently processed by the XCMS toolbox (version 1.14.0, 
http://masspec.scripps.edu/xcms/xcms.php) using XCMS’s default settings with the following 
changes: xcmsSet (fwhm = 8, snthresh = 6, max = 200), retcor (method = “linear,” 
family = “gaussian,” plottype = “mdevden”), bandwidth (bw) of 8 for first grouping and 4 for 
second grouping [29,30]. For multivariate statistical analysis, the XCMS output was further 
processed using Microsoft Excel (Microsoft, Redmond, WA, USA). The data of IS and impurity 
peaks from column bleeds and vessels were excluded, and only ion features between RTs 320 
and 2400 s were normalized within the sample and arranged on a three-dimensional matrix 
consisting of arbitrary peak index (RT–m/z pair), sample names (observations), and peak area 
(variables). For comparing relative derivatization efficiency, the base peak areas of standards or 
test compounds in fecal samples were selected and calibrated by EMP. 
 
Multivariate statistical analysis and univariate statistical validation 
The resulting three-dimensional data table was entered into the SIMCA-P 11.0 software package 
(Umetrics, Umeå, Sweden), where multivariate statistical analyses, including PCA and PLS–DA, 
were performed. All data was mean-centered and unit variance (UV)-scaled before PCA and 
PLS–DA. PCA was used to observe general clustering and trends among all samples extracted 
from feces by acidified, alkalized, and deionized water, respectively, or between fresh and frozen 
feces samples. Meanwhile, the PLS–DA model, as a method derived from PLS analysis where 
the Y matrix was set as a dummy descriptor by Simca-P, was used to maximize metabolite 
variations and identify significantly altered metabolites responsible for such variations. R2X 
represents the cumulative modeled variation in X, R2Y is the cumulative modeled variation in Y, 
and Q2Y is the cumulative predicted variation in Y. The values of these parameters approaching 
1.0 indicated a stable model with a predictive reliability. These discriminating metabolites were 
obtained by using a statistically significant threshold of variable influence on projection 
(VIP > 1.0) values obtained from the PLS–DA model and were further validated by Student’s t 
test. The metabolites with VIP values greater than 1.0 and P values less than 0.05 (threshold) 
were selected as discriminating metabolites between two classes of samples. Fold was calculated 
as the logarithm of the average mass response (area) ratio between two arbitrary classes, where 
the positive value means that the average mass response of class 1 is larger than that of class 2. 
 
Identification and quantification of human fecal water metabolites 
Compound identification was performed by comparing the RTs and mass spectra of each peak 
with those of reference standards available in our lab. The remaining compounds were identified 
by search against commercially available libraries such as NIST05, NBS, and Wiley databases. 
The measured mass spectra were deconvoluted by the Automated Mass Spectral Deconvolution 
and Identification System (AMDIS) before comparing with the databases. Then the mass spectra 
of individual components were transferred to the NIST Mass Spectral Search Program MS 
Search 2.0, where they were matched against reference compounds of the NIST Mass Spectral 
Library 2005. GC/MS data from unidentified compounds were further processed by TurboMass 
5.3.0 for comparison of their mass spectra with NBS and Wiley databases. Further validation of 
these candidate compounds by library research was performed by checking CI mass spectra, and 
this helped to obtain the molecular weight of the derivative, the reaction laws (Fig. 2), and the EI 
mass spectra. Calibration curves of 34 reference standards were used to quantify the compounds 
of fecal water. 
 
 
Figure 2: Reaction scheme of three representative compounds treated with ECF in current 
aqueous reaction system: (A) valeric acid; (B) tyrosine; (C) 3-(4-hydroxyphenyl)propionic acid. 
R1 or R2 represents alkyl group such as –CH3, –C2H5, –C3H7, or –C4H9. 
 
 
 
 
 
RESULTS AND DISCUSSION 
Chromatographic separation 
Fecal water is a complex mixture of various metabolites, including fatty acids, amino acids, 
amines, and phenolic compounds, with a wide range of boiling points. The application of ECF 
derivatization in fecal water is beneficial not only to decrease the boiling points of metabolites 
but also to narrow the boiling point window of the derivatives. Consequently, capillary gas 
chromatography separation can cover as many compounds as possible. When the initial oven 
temperature was decreased from 80 to 40 °C, a large number of short-chain fatty acids, such as 
2-methylbutyric, isovaleric, and valeric acids, were identified as important because many short-
chain fatty acids exist abundantly in fecal water [9,31]. The Agilent RTL technique is a powerful 
means for reproducing compound RTs of gas chromatograms, and this is important for 
accurately assigning peaks in processing data. It was found that RTL efficiently controlled the 
RT accuracy within batch and between different batches. But we found that the increased 
variation of RTs occurred in the low oven temperature region, and this usually happened in the 
initial two runs. The optimized oven temperature program and RTL technique allowed good 
chromatographic separation and repeatability of RTs. 
 
 
 
Derivatization reagents 
The reaction system was generally composed of alkyl chloroformate, water, alcohol, and 
pyridine. Here pyridine triggers derivatization reaction, whereas both the length of the alkyl 
group and the kinds of alcohol affect the structures of derivatives. Therefore, two kinds of alkyl 
chloroformates (methyl- and ethyl-) and four kinds of alcohols (methanol, ethanol, propanol, and 
n-butanol) were evaluated for the derivatization of test compounds aiming to obtain better 
separation and sensitivity (Fig. 3). If methanol was selected, the short-chain fatty acids (2-
methylbutyric acid and isovaleric acid) were overlapped by solvent peaks even if the initial 
column temperature was decreased to 40 °C. The application of ethanol increased the RT and 
peak intensity. Propanol and n-butanol further enhanced the RT, but the intensity and purity of 
derivatives were seriously affected. Alkyl chloroformate principally affected the peak intensity; 
ECF showed better peak intensity of derivatives, especially amino acids, than did methyl 
chloroformate. 
 
 
Figure 3: Effects of alkyl chloroformate and alcohol on derivatization of water-soluble 
standards. 
 
Alkyl chloroformates contain methyl chloroformate and ethyl chloroformate. Alcohols include methanol, ethanol, propanol, and n-butanol. 
 
 
During the derivatization reaction, the amino and hydroxyl groups are converted into the 
structurally stable alkoxycarbonyl esters. But the carboxylic groups are transformed to the 
structurally unstable alkoxycarbonyl esters or stable alkyl esters by an exchange reaction with 
alcohol in the reaction medium. Thus, the final derivatives of compounds containing carboxylic 
groups were determined by alcohol types and reaction conditions such as the water/alcohol ratio. 
In this experiment, the solvent pair ECF and ethanol showed the better peak intensity, separation, 
and derivatization purity and was selected as the optimal reaction reagents. 
 
 
Factors affecting the efficiency of derivatization 
The water/ethanol/pyridine ratio. During the derivatization process, the content of ethanol or 
water affects the solubility of compounds in the reaction medium and the consequent reaction 
recovery. Fig. 4 indicates that water improved the derivatization efficiencies of most test amino 
acids except the hydrophobic amino acids (e.g., alanine, proline) and of all test compounds 
containing the active hydroxyl groups. In contrast, water inhibited the derivatization of 
carboxylic acids, especially long-chain fatty acids. Moreover, the decrease in reaction yield is 
proportional to the increase in carbon chain length of acids. Ethanol enhanced the derivatization 
efficiencies of all carboxylic acids without active hydroxylic groups, especially long chains of 
fatty acids (Fig. 4). It was known that ethanol promoted not only the dissolution of hydrophobic 
compounds in reaction mixture but also the esterification of the carboxylic group by exchanging 
the unstable alkoxycarbonyl esters with ethanol to the stable alkyl esters instantly. Therefore, 
high ethanol content was beneficial for the derivatization of carboxylic acids and hydrophobic 
compounds. Previously published data demonstrated that the excessive alcohol corresponding to 
the reagent alkyl (e.g., ethanol) promoted the esterification of di- or tricarboxylic acids favorably 
[32]. More water will decrease reaction yield [33] and [34], and then the amount of water should 
be as low as possible. Therefore, the water/ethanol ratio affected not only the solubility of 
compounds but also their esterification and purification of derivative products; thus, the precise 
water/ethanol ratio should be controlled to minimize the formation of side products. Pyridine is 
necessary for triggering catalyst reaction in the aqueous medium. It was found that 50 μl of 
pyridine received better effects for nearly all test compounds (data not shown). For the category 
analysis of metabolites in fecal water, we compromised by using a water/ethanol/pyridine ratio 
of 12:6:1 (total volume 950 μl). 
 
One-step versus two-step derivatization. In many publications, the classical one-step 
derivatization without pH adjustment is normally applied to obtain derivatives rapidly with 
regard to one given class of compounds. In our work, we found that dicarboxylic acids and 
glutamic acid (amino derivative of glutaric acid) produced very weak signals in one-step 
derivatization. Two-step derivatization [20] significantly improved the relative derivatization 
efficiency of amino acids, short-chain fatty acids and dicarboxylic acids, and phenolic 
compounds containing hydroxyl groups (phenolic acids), whereas only the long-chain fatty acids 
(mono- and dicarboxylic acids) were decreased slightly (Fig. 5). If the same content of NaOH 
and ECF that are added during the second step of the two-step method were added into the 
reaction medium for the one-step method, only long-chain fatty acids would obtain higher 
derivatization efficiencies than those of the one-step method without pH adjustment and the two-
step derivatization. In addition, it was surprising to observe that the derivatization of phenolic 
acids, short-chain dicarboxylic acids, and amino acids was depressed in contrast to the two-step 
derivatization, where 3,4-dihydroxyphenylacetic acid was significantly inhibited or could not be 
detected, suggesting that these phenolic compounds were possibly transformed to quinone 
compounds by NaOH before starting derivatization. Consequently, the two-step derivatization 
with pH regulation by NaOH at the second step was superior to the one-step derivatization and 
the one-step derivatization with initial pH regulation. 
 
 
 
 
Figure 4: Effects of water/ethanol ratio on derivatization of monocarboxylic and dicarboxylic 
acids, phenolic compounds, and amino acids.  
 
 
The raw extracted mass spectral data were calibrated by EMP, which was added at the last vortex. 
  
Figure 5: Comparison of derivatization efficiencies between one-step and two-step 
derivatizations. 
 
 
The raw extracted mass spectral data were calibrated by EMP, which was added at the last vortex. The results are shown for monocarboxylic 
acids (A), dicarboxylic acids (B), phenolic compounds (C), and amino acids (D), for which traditional one-step derivatization (I), two-step 
derivatization (II), and one-step derivatization with NaOH regulation (III) were compared. 
 
 
Initial pH. Based on the two-step method, the effects of initial pH of reaction medium on 
derivatization efficiency were evaluated. The effects of sodium bicarbonate (0.1–1.0 mol L−1, 
final concentration) and formic acid (0.01–0.1 mol L−1, final concentration) aqueous solution in 
initial reaction medium with control derivatization (deionized water) were compared (Table 1). 
Formic acid significantly inhibited the derivatization of most test compounds, especially amino 
acids, possibly due to the weak ionization of amino acids in acidic water. The low content of 
sodium bicarbonate (0.1 mol L−1, final concentration) improved the reaction yields of most test 
compounds except benzoic acid and its analogs and short-chain dicarboxylic acids, whereas the 
high content of sodium bicarbonate (e.g., 1 mol L−1, final concentration) seriously suppressed the 
reaction yields, especially for amino acids. 
 
It is known that carboxylic groups are transformed either to unstable alkoxycarbonyl esters, 
which are decomposed slowly over time, or to the stable alkyl esters [35]. The low content of 
sodium bicarbonate not only promoted the ionization of the carboxylic groups in aqueous 
medium but also improved decarboxylation of alkoxycarbonyl esters to the desired alkyl esters. 
Meanwhile, the alkalized environment provided by sodium bicarbonate neutralized the free acids 
released during the decarboxylation reaction. The high content of sodium bicarbonate produced 
the excess free acids, especially short-chain dicarboxylic acids, during its competitive 
decarboxylation reaction with ethanol, and this probably caused feedback repression. Therefore, 
the combination of adding sodium bicarbonate at the first step (0.1 mol L−1, final concentration) 
and NaOH at the second step (1 mol L−1, final concentration) was the optimum means of initial 
pH adjustment. 
 
Effects of solvents on extraction yields of fecal water compounds 
For metabonomics research, an appropriate extraction method not only covers more compounds 
but also obtains higher extraction yields of all compounds. Many factors affect the extraction 
yields of fecal water and even the final results. This work compared the extraction efficiencies of 
formic acid (0.2 mol L−1), NaOH aqueous solution (0.15 mol L−1), and deionized water on feces. 
Visual inspection of GC/MS TIC chromatograms revealed some differences in peak intensities. 
The raw data were calibrated by IS (l-2-chloro-phenylalanine) prior to PCA and PLS–DA 
analysis using Simca-P 11.0 software. A clear separation in scores plot of PCA occurred among 
the three groups of samples, where the cumulative R2X of two principal components, 0.733, 
indicated the significantly different metabolite profiles caused by the pH of the extraction 
solvent. The separate PLS–DA models were conducted to reveal the variables that had the 
greatest contribution to the discrimination among the three pH conditions. Combining the results 
of VIP values (>1) of the PLS–DA model and the Student’s t test (P < 0.05), it was found that 
both deionized water and NaOH solution showed better extraction efficiency on nearly all kinds 
of compounds than did formic acid aqueous solution (Table 2). The acidification probably 
inhibited the solubility of fecal compounds by affecting their ionization status in an aqueous 
medium. Water significantly improved the extraction yields of fatty acids and phenolic 
compounds compared with NaOH, whereas NaOH merely promoted the extraction of amino 
acids compared with deionized water. Such results indicate that the basic pH facilitates the 
solubility of the metabolites containing amino- or amide-functional groups, whereas fatty acids 
and phenolic compounds are preferably resolved in water. Considering that suitable extraction 
solvent must aim at recovering all classes of compounds, selecting water rather than acidified or 
alkalized water as the extraction solvent helped to obtain more information on fecal water 
metabolites. 
 
Storage conditions of feces samples 
For metabonomics research, the instant preparation of a large number of fecal water samples has 
been a hard task and a great challenge, and it may cause metabolite information distortion due to 
the metabolism of massive gut microorganisms and the alteration of their living environment in 
postcollection feces. Freezing the feces immediately after collection is an alternative method that 
can further benefit multicentric studies where the best standardization can be met if all samples 
are prepared in the same laboratory. It was found that the signals of amino acids were obviously 
stronger in fecal water prepared from frozen–thawed aliquots than from fresh aliquots of the 
same stool specimens. The scores plots of PCA (R2X = 0.944) and PLS–DA (R2X = 0.521, 
R2Y = 0.982, Q2Y = 0.949) models from UV-scaled data confirmed a clear separation between 
both preparations. The compounds with VIP values of the PLS–DA model greater than 1 were 
selected as the discriminating metabolites and further quantified. Table 3 indicates that all amino 
acids and two dicarboxylic acids (succinic acid and malic acid) were significantly increased in 
frozen fecal samples, and this was also supported by Saric and coworkers’ work [36]. It is known 
that basic pH improves the extraction of amino acids, but this work indicates that no difference 
of pH occurred between fresh and frozen fecal water. It is presumed that these discriminating 
compounds were probably released from matrix during the freezing and thawing of fecal  
Table 2: Differential compounds among samples extracted by deionized water, formic acid, and NaOH aqueous solution 
from the same human feces. 
Compound NaOH vs. formic acid  Water vs. formic acid  Water vs. NaOH 
VIP value P value (t test) Fold  VIP value P value (t test) Fold  VIP value P value (t test) Fold 
Fatty acids            
2-Methylbutyric acid — — —  3.63 0.023 0.16 ↑  2.71 7.85 × 10−3 0.15 ↑ 
Isovaleric acid — — —  3.72 0.040 0.14 ↑  2.92 6.96 × 10−3 0.16 ↑ 
Valeric acid — — —  — — —  3.07 0.011 0.15 ↑ 
Hexanoic acid — — —  5.53 0.016 0.19 ↑  3.22 0.024 0.13 ↑ 
Heptanoic acid 3.34 8.28 × 10−6 0.28 ↑  3.97 1.34 × 10−3 0.36 ↑  — — — 
Succinic acid — — —  6.61 2.34 × 10−5 0.38 ↑  6.11 7.55 × 10−7 0.40 ↑ 
Fumaric acid — — —  1.556 1.37 × 10−3 0.62 ↑  1.65 1.20 × 10−4 0.91 ↑ 
Caprylic acid 2.40 3.54 × 10−9 0.57 ↑  2.48 2.24 × 10−4 0.57 ↑  — — — 
Malic acid — — —  2.12 5.70 × 10−4 0.74 ↑  2.12 1.41 × 10−5 1.04 ↑ 
Myristic acid — — —  1.45 5.03 × 10−6 0.53 ↑  — — — 
Pentadecanoic acid 1.77 1.59 × 10−4 0.29 ↑  3.29 3.67 × 10−7 0.61 ↑  2.45 8.88 × 10−7 0.32 ↑ 
Stearic acid — — —  5.10 7.01 × 10−7 0.40 ↑  5.59 1.90 × 10−7 0.37 ↑ 
Heptadecanoic acid — — —  1.60 1.32 × 10−6 0.49 ↑  1.37 1.84 × 10−7 0.39 ↑ 
Palmitic acid 1.83 0.010 −0.16 ↓  5.51 7.40 × 10−5 0.29 ↑  4.79 5.92 × 10−8 0.45 ↑ 
         
Phenolics            
Phenylacetic acid 4.52 0.021 0.04 ↑  6.18 0.0153 0.16 ↑  3.17 0.014 0.12 ↑ 
p-Cresol — — —  — — —  1.00 0.034 0.09 ↑ 
3-Phenylpropionic 
acid 
3.44 1.95 × 10−4 0.15 ↑  4.21 3.8 × 10−3 0.25 ↑  1.30 0.036 0.10 ↑ 
            
Amino acids            
Alanine 7.48 2.05 × 10−7 0.55 ↑  6.169 9.63 × 10−6 0.39 ↑  5.41 2.88 × 10−4 −0.16 ↓ 
Valine 10.60 5.41 × 10−7 0.70 ↑  8.08 2.50 × 10−5 0.44 ↑  8.34 7.85 × 10−5 −0.26 ↓ 
Leucine 11.47 1.08 × 10−9 0.72 ↑  7.75 3.29 × 10−5 0.37 ↑  9.86 1.05 × 10−7 −0.35 ↓ 
Isoleucine 10.41 5.94 × 10−7 0.71 ↑  7.96 2.20 × 10−5 0.46 ↑  8.14 8.46 × 10−5 −0.26 ↓ 
Proline 4.91 7.50 × 10−5 0.55 ↑  4.42 1.92 × 10−5 0.46 ↑  — — — 
Aspartic acid 5.53 7.67 × 10−5 0.49 ↑  — — —  5.94 7.48 × 10−5 −0.50 ↓ 
Methionine 3.13 4.52 × 10−8 0.71 ↑  1.76 1.58 × 10−5 0.35 ↑  2.91 8.41 × 10−7 −0.37 ↓ 
Glutamic acid 2.84 9.62 × 10−5 0.29 ↑  2.51 5.89 × 10−6 0.24 ↑  — — — 
Phenylalanine 6.59 4.64 × 10−9 0.73 ↑  3.84 5.85 × 10−4 0.33 ↑  6.05 7.66 × 10−8 −0.40 ↓ 
Lysine 3.52 5.99 × 10−8 0.68 ↑  1.79 6.07 × 10−4 0.35 ↑  3.27 5.36 × 10−6 −0.33 ↓ 
Tyrosine 6.31 1.88 × 10−9 0.84 ↑  2.84 5.74 × 10−6 0.33 ↑  6.16 1.15 × 10−8 −0.52 ↓ 
           
Unknown compounds            
Unknown-1 1.86 7.69 × 10−5 0.74 ↑  1.50 1.02 × 10−3 0.57 ↑  1.28 0.035 −0.17 ↓ 
Unknown-2 2.55 7.15 × 10−5 0.59 ↑  1.82 1.61 × 10−6 0.40 ↑  2.08 8.09 × 10−3 −0.19 ↓ 
Unknown-3 — — —  1.34 1.31 × 10−7 1.20 ↑  1.21 4.51 × 10−8 0.61 ↑ 
Unknown-4 4.00 8.34 × 10−5 1.22 ↑  2.59 1.48 × 10−7 0.85 ↑  3.46 2.08 × 10−3 −0.37 ↓ 
Unknown-5 1.13 7.11 × 10−6 0.77 ↑  1.92 1.7 × 10−3 0.46 ↑  1.01 5.54 × 10−4 −0.31 ↓ 
Unknown-6 1.61 1.53 × 10−5 0.31 ↑  2.37 1.13 × 10−6 0.50 ↑  1.38 1.05 × 10−5 0.19 ↑ 
Unknown-7 3.31 6.19 × 10−6 0.50 ↑  — — —  3.70 1.16 × 10−5 −0.65 ↓ 
 
 
samples. Considering the variations introduced by freezing–thawing, we recommend preparing 
fecal water from freshly collected fecal samples. However, it would be prudent to use frozen 
feces when a large batch of samples must be analyzed in an acceptable time frame. 
 
 
 
 
 
 
 
 
Table 3: Quantitative analysis of discriminating metabolites obtained by PLS–DA model 
(VIP > 1) between fresh and frozen fecal samples. 
Compound Content (μg ml−1)a VIP value Student’s t test (P value) 
Fresh feces Frozen feces 
Leucineb 1.48 ± 0.84 29.37 ± 19.04 3.94 3.958 × 10−6 
Valeric acid 151.43 ± 31.13 123.69 ± 45.34 3.85 0.182 
Valineb 1.72 ± 0.57 22.34 ± 11.97 3.43 2.533 × 10−7 
Succinic acidb 10.74 ± 6.12 62.67 ± 40.54 3.23 2.994 × 10−5 
Isoleucineb 0.76 ± 0.43 16.07 ± 9.23 3.13 5.242 × 10−7 
Alanineb 7.88 ± 2.64 62.70 ± 33.82 2.92 7.141 × 10−7 
3-Phenylpropionic acid 40.58 ± 24.64 29.15 ± 21.52 2.86 0.322 
Phenylacetic acid 46.03 ± 28.61 48.52 ± 47.14 2.79 0.594 
Hexanoic acid 42.21 ± 70.95 33.81 ± 42.39 2.67 0.467 
2-Methylbutyric acid 99.41 ± 53.31 93.74 ± 71.65 2.66 0.900 
Glutamic acidb 59.98 ± 37.91 522.66 ± 154.09 2.43 4.214 × 10−12 
Prolineb 1.98 ± 1.09 16.41 ± 7.23 2.21 1.932 × 10−8 
Isovaleric acid 72.91 ± 38.00 69.47 ± 54.40 2.16 0.851 
Tyrosineb 8.38 ± 3.39 109.72 ± 58.91 2.11 2.696 × 10−7 
Malic acidb 1.476 ± 1.069 30.09 ± 11.97 2.1 4.655 × 10−10 
Phenylalanineb 1.75 ± 0.87 22.92 ± 13.88 1.91 1.956 × 10−6 
3-Hydroxyphenylacetic acid 13.20 ± 5.91 9.34 ± 6.41 1.24 0.349 
Glutaric acid 31.25 ± 12.59 20.13 ± 13.94 1.21 0.350 
aValues are means ± standard deviations. 
bThe discriminating compounds with VIP values of the PLS–DA model greater than 1 were further significantly validated by quantitative analysis 
with Student’s t test (P < 0.05). 
 
Method validation 
The quantitative performance of the extraction and derivatization methods coupled with GC/MS 
analysis was investigated in terms of linearity and sensitivity. Using the optimized derivatization 
and GC/MS methods, a regression coefficient higher than 0.99 for each calibration curve from 
the spiked standards was obtained, indicating good linearity. Exceptions were three fatty acids 
(palmitic, stearic, and oleic acids) and two phenolic acids (4-hydroxybenzoic and 3-(4-
hydroxyphenyl)propionic acids) that showed weak linearity at high concentrations, presumably 
due to the low solubility in an aqueous reaction system; thus, the data of high concentration were 
excluded in calculating R2 for these substances. The LODs of most of the test standards were 10 
to 500 pg on-column, indicating that this developed method is appropriate to analyze fecal water. 
 
The analytical equipment exhibited excellent repeatability, with the relative standard deviations 
(RSDs) lower than 4% for all test standards (Table 4) and lower than 7% for 31 test compounds 
identified in fecal water samples (Fig. 6). The derivatization method also showed good 
repeatability, with RSDs lower than 6.4% for test standards (with the exception of 3,4-
dihydroxyphenylacetic acid) (Table 4) and lower than 10% for 28 test compounds (except for 
two dicarboxylic acids and one phenolic compound) in fecal water from healthy volunteers (Fig. 
6). The derivatives showed good stability for 48 h, and no obvious degradation occurred if stored 
at −80 °C for 2 months. 
 
 
 
 
 
 
 
 
 
Table 4: Linearity, limit of detection (LOD), and repeatability for GC/MS analysis of 34 standards. 
Compound R2a Linear range 
(μg ml−1) 
n LODb  Repeatability (RSD)c 
Picograms on-column Signal/noise  GC/MS Derivatization 
Monocarboxylic acids         
2-Methylbutyric acid 0.9983 0.1–25 9 100 26  3.29 2.93 
Isovaleric acid 0.9978 0.1–25 9 100 31  2.89 5.54 
Valeric acid 0.9976 0.25–25 8 250 37  2.57 3.39 
4-Methylvaleric acid 0.9978 0.25–25 8 100 21  1.75 3.34 
Hexanoic acid 0.9982 0.05–25 1
0 
50 10  2.12 3.99 
Cyclohexane carboxylic acid 0.9978 0.1–25 9 50 22  3.26 2.70 
Nonanoic acid 0.9972 0.05–25 1
0 
50 11  2.46 3.48 
Myristic acid 0.9929 0.05–25 1
0 
10 18  2.18 4.55 
Palmitic acid 0.9871 0.05–12.5 9 10 8  2.10 4.95 
Oleic acid 0.9951 0.5–12.5 6 250 3.6  3.87 5.92 
Stearic acid 0.9829 0.05–12.5 9 10 19  2.80 5.75 
          
Dicarboxylic acids         
Succinic acid 0.9942 0.5–25 7 500 23  1.68 4.97 
Methylsuccinic acid 0.9946 0.25–25 8 250 26  1.16 6.40 
Glutaric acid 0.9960 0.5–25 7 500 17  2.04 2.80 
Malic acid 0.9943 0.5–25 7 250 3.5  2.75 3.26 
Suberic acid 0.9997 0.5–25 7 250 7  1.61 2.31 
Sebacic acid 0.9984 0.5–25 7 250 9  1.82 2.94 
          
Phenolics         
p-Cresol 0.9985 0.25–25 8 100 8  1.95 2.60 
Benzoic acid 0.9974 0.05–25 1
0 
10 12  3.46 4.78 
Phenylacetic acid 0.9990 0.25–25 8 250 25  1.96 2.90 
3-Phenylpropionic acid 0.9990 0.25–25 8 100 5  1.39 2.67 
4-Hydroxybenzoic acid 0.9982 0.5–12.5 6 250 8  1.46 3.62 
3-Hydroxyphenylacetic acid 0.9995 0.5–25 7 250 4  1.27 2.78 
4-Hydroxyphenylacetic acid 0.9937 0.5–25 7 250 8.6  1.10 2.79 
3-(4-Hydroxyphenyl)propionic acid 0.9994 0.5–12.5 6 500 10  0.95 2.94 
3,4-Dihydroxyphenylacetic acid 0.9908 2.5–25 5 2500 11  3.47 13.84 
          
Amino acids         
Alanine 0.9977 1–25 6 1000 18  1.90 2.37 
Valine 0.9993 0.25–25 8 100 7  1.53 2.04 
Leucine 0.9996 0.25–25 8 100 10  1.32 1.45 
Isoleucine 0.9993 0.1–25 9 100 13  1.80 2.54 
Proline 0.9953 0.25–25 8 100 4  1.80 2.50 
Glutamic acid 0.9936 2.5–25 5 2500 12  3.92 8.01 
Phenylalanine 0.9998 0.5–25 7 250 5.6  1.35 0.69 
Tyrosine 0.9987 2.5–25 5 1000 8.7  3.52 3.39 
aRegression coefficients were calculated for linearity ranging at the concentration listed here. 
bLOD (pg on-column) is the lowest calibration standard injected with a signal/noise ratio ⩾3, where the signal/noise ratio calculation was carried out to display the peak-to-peak 
values by Agilent ChemStation software. 
cRepeatability of the test compounds from the spiked standard solution (5 μg ml−1) with the same derivatization sample (GC/MS) and different derivatization samples (derivatization) 
with the same spiked standard solution (n = 7). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Repeatability of 31 test compounds from fecal water samples, including GC/MS 
instrument (n = 6) and derivatization method (n = 5). 
 
 
 
 
Qualitative and quantitative analysis on human fecal water 
Using the validated method combining sample derivatization of ECF and GC/MS analysis, fecal 
water samples from healthy human subjects were analyzed. Approximately 180 metabolites were 
identified from human fecal water samples; of these, 57 compounds were structurally confirmed 
by comparing their RTs and EI mass spectra with reference standards available in our lab (Table 
5). The unknown peaks were further investigated by search against mass spectral databases such 
as NIST05, NBS, and Wiley, where candidate compounds were listed according to structural 
possibility. The EI ion source provided weak information about molecular ion. To further 
validate the results provided by library research, GC/MS in CI mode using methane reagent gas 
was conducted to obtain more information about molecular weights. At first, the reference 
standards were injected. The ions [M+1]+, [M+29]+, and [M+41]+, which represent methane 
adducts [37], were clearly present in all CI spectra of test standards. Such characteristics 
positively confirmed the correct assignment of the [M+1]+ ion in CI spectra. From the molecular 
weights (MWs) obtained from CI spectra and the reaction principle of ECF derivatization (Fig. 
2), we preliminarily validated 16 candidate compounds provided by library research 
(summarized in Table 5). 
Table 5: Compounds identified and confirmed in human fecal water. 
No. Fecal compounds  ECF derivatives of fecal compounds 
Name MW  RT MW EI mass spectruma(m/z) CI (m/z) 
[M+H]+ [M+C2H5]
+ 
[M+C3H5]
+ 
1 Butanoic acid 88  5.52 116 71, 88, 43, 60, 101 117 145 157 
2 2-Methylbutyric acid 102  6.23 130 57, 102, 41, 74, 85 131 159 171 
3 Isoveleric acid 102  6.29 130 88, 85, 57, 41, 60 131 159 171 
4 Valeric acid 102  7.27 130 88, 85, 57, 41, 101 131 159 171 
5 N-Methylalanineb 103  8.37 131 116, 44, 86, 72, 58 132 160 172 
6 4-Methylvaleric acid 116  8.55 144 88, 101, 43, 81, 55 145 173 185 
7 Hexanoic acid 116  9.25 144 88, 99, 43, 101, 60 145 173 185 
8 n-Propylamineb 59  9.75 131 102, 43, 131, 58, 86 132 160 172 
9 N,N-Dimethyl-l-alanineb 117  10.24 145 116, 44, 58, 72, 100 146 174 186 
10 Propanedioic acid 104  10.70 160 115, 133, 43, 88, 60 161 189 201 
11 Heptanoic acidb 130  11.22 158 88, 113, 43, 101, 60 159 187 199 
12 3-(Methylthio)propionic acid 120  11.28 148 74, 148, 75, 61, 103 149 177 189 
13 Butylamineb 73  11.67 145 102, 145, 115, 133 146 174 186 
14 Cyclohexane carboxylic acid 128  11.91 156 83, 55, 101, 156, 111 157 185 197 
15 Benzoic acid 122  12.64 150 105, 77, 122, 87, 150 151 179 191 
16 Succinic acid 118  12.78 174 101, 129, 174 175 203 215 
17 Fumaric acid 116  12.88 172 127, 99, 71, 54 173 201 213 
18 Caprylic acid 144  13.09 172 88, 101, 127, 57, 73 173 201 213 
19 Methylsuccinic acid 132  13.27 188 143, 115, 142, 73, 87 189 217 229 
20 1-Piperidine carboxylic acidb 129  13.48 157 128, 84, 157, 56, 42 158 186 198 
21 Phenylacetic acid 136  14.00 164 91, 164, 65 165 193 205 
22 Alanine 89  14.46 189 116, 44, 72 190 218 230 
23 Glutaric acid 132  14.59 188 143, 114, 87, 142, 188 189 217 229 
24 Nonanoic acid 158  14.84 186 88, 101, 141 187 215 227 
25 Indoleb 117  14.90 — 117, 90, 89, 63, 57 118 146 158 
26 Glycine 75  15.22 175 102, 90, 144, 73, 41 176 204 216 
27 p-Cresol 108  15.62 180 108, 107, 77, 180 181 209 221 
28 Cyclohexylamineb 99  15.76 171 128, 142, 171, 56 172 200 212 
29 3-Phenylpropionic acid 150  15.87 178 104, 91, 178, 105 179 207 219 
30 Hexanedioic acidb 146  16.42 202 157, 111, 128, 115, 55 203 231 243 
31 Valine 117  16.62 217 144, 72, 116 218 246 258 
32 Leucine 131  17.97 231 158, 102, 44, 58 232 260 272 
33 Pimelic acid 160  18.25 216 125, 129, 171, 101, 69 217 245 257 
34 Isoleucine 131  18.26 231 158, 102, 129, 69, 74 232 260 272 
35 9-Oxo-nonanoic acidb 172  18.64 200 88, 157, 55, 101, 83 201 229 241 
36 Proline 115  18.70 215 142, 70, 98, 41, 215 216 244 256 
37 Malic acid 134  20.01 262 71, 117, 89, 43, 55 263 291 303 
38 Suberic acid 174  20.22 230 185, 143, 138, 88, 115 231 259 271 
39 Dodecanic acid 200  20.35 228 88, 101, 183, 73, 157 229 257 269 
40 Aspartic acid 133  21.57 261 188, 116, 70, 142 262 290 302 
41 Nonanedioic acidb 188  22.21 244 199, 152, 157, 55, 83 245 273 285 
42 3- or 4-Hydroxybenzoic acid 138  22.86 238 121, 91, 138, 120, 149 239 267 279 
43 Methionine 149  22.99 249 61, 175, 129, 176, 116 250 278 290 
44 Glutamic acid 147  23.96 275 202, 128, 84, 156, 56 276 304 316 
45 3-Hydroxyphenylacetic acid 152  24.07 252 107, 180, 108, 179 253 281 293 
46 Sebacic acid 202  24.17 258 213, 171, 84, 240, 125 259 287 299 
47 Myristic acid 228  24.28 256 88, 101, 43, 55, 157 257 285 297 
48 4-Hydroxyphenylacetic acid 152  24.55 252 107, 135, 180 253 281 293 
49 Phenylalanine 165  25.33 265 176, 192, 91, 102, 120 266 294 306 
50 3-(2-Hydroxyphenyl)propionic acid 166  26.08 266 120, 149, 194, 91, 107 267 295 307 
51 Pentadecanoic acidb 242  26.21 270 88, 168, 101, 43, 55 271 299 311 
52 3-(3- or 4-Hydroxyphenyl)propionic acid 166  26.63 266 120, 107, 123, 135, 194 267 295 307 
53 3-(3- or 4-Hydroxyphenyl)-2-propenoic acidb 164  27.02 264 176, 222, 107, 120, 148 265 293 305 
54 Homovanillic acid 182  27.74 282 137, 210, 282, 165, 122 283 311 323 
55 Palmitic acid 256  28.10 284 88, 101, 43, 284, 55 285 313 325 
56 p-Coumaric acid 164  28.86 264 147, 192, 120, 164, 264 265 293 305 
57 Hydroferulic acid 196  29.67 296 137, 150, 224, 296, 91 297 325 337 
58 Heptadecanoic acidb 270  29.91 298 88, 101, 43, 55, 120 299 327 339 
59 Pyrogallol 126  30.00 342 126, 97, 154, 225, 108 343 371 383 
60 Tyramine 137  30.71 281 120, 107, 102, 192, 282 310 322 
61 Linoleic acid 280  31.12 308 67, 81, 95, 55, 109, 308 309 337 349 
62 Oleic acid 282  31.21 310 55, 69, 41, 88, 83 311 339 351 
63 cis-11- or 13-Octadecenoic acidb 282  31.40 310 55, 69, 41, 83, 97 311 339 351 
64 Stearic acid 284  31.67 312 88, 101, 312, 43, 55 313 341 353 
65 Lysine 146  31.81 318 156, 84, 56, 102, 128 319 347 359 
66 3,4-Dihydroxyphenylacetic acid 168  31.99 340 123, 196, 223, 135, 151 341 369 381 
67 Ferulic acid 194  32.11 294 222, 150, 177, 145, 294 295 323 335 
68 Phloroglucinol 126  32.82 342 126, 154, 98, 69, 110 343 371 383 
69 2,3- or 2, 5- or 3, 5-Dihydroxyphenylacetic acidb 168  33.03 340 123, 196, 124, 267, 151 341 369 381 
70 3,4-Dihydroxyphenylpropionic acid 182  33.78 354 136, 123, 210, 164, 237 355 383 395 
71 Tyrosine 181  34.83 353 107, 192, 264, 135, 102 354 382 394 
72 Sinapinic acid 224  35.15 324 252, 180, 207, 324, 280 325 353 365 
73 Tryptophan 204  36.15 304 130, 55, 304 305 333 345 
aIons in italics were base peaks. 
bResults were obtained by researching the EI mass spectral database and were further validated by CI mass spectra. 
 
Table 5 indicates that the predominant compounds were carboxylic acids, especially fatty acids, 
amine, amino acids, and phenolic compounds. The current method could not derivatize the 
inactive compounds such as carbohydrates, alcohol, and trimethylamine. Formic acid, acetic 
acid, and propionic acid could not be detected because of the low boiling point of their 
derivatives. In contrast to the NMR method, the current method identified and qualified more 
compounds, especially metabolites present in low amounts in fecal water. Bile acids in fecal 
water are a class of important compounds affecting intestinal health. The current method can 
derivatize only carboxylic groups of bile acid rather than hydroxylic groups; as a result, their 
derivatives were eluted at the region of extremely high column temperature, which is out of the 
scope of this method. In addition, the mass intensity is significantly lower than that of the other 
kinds of compounds in this research. 
 
The compounds present in healthy human fecal water were analyzed quantitatively using the 
calibration curves of reference standards. Table 6 showed that the predominant components were 
valeric, isovaleric, 2-methylbutyric, hexanoic, phenylacetic, 3-phenylpropionic, and glutamic 
acids in healthy human fecal water. A high standard deviation is a typical characteristic of human 
fecal specimens, and this may be a difficulty when searching for differences in fecal water 
metabolome of human subjects having pathologies. 
 
Table 6: Quantitation of test standards in healthy human fecal water samples (n = 8, μg ml−1). 
Compound Contenta Compound Contenta 
Valeric acid 337.74 ± 128.32 Phenylalanine 6.90 ± 6.96 
Isovaleric acid 165.74 ± 68.68 Leucine 6.66 ± 8.05 
Phenylacetic acid 119.54 ± 57.96 Valine 5.81 ± 6.45 
3-Phenylpropionic acid 77.30 ± 32.98 Suberic acid 4.06 ± 3.31 
Hexanoic acid 77.00 ± 89.84 Cyclohexane carboxylic acid 3.73 ± 7.36 
2-Methylbutyric acid 75.16 ± 23.11 3,4-Dihydroxyphenylacetic acid 3.72 ± 0.87 
Glutamic acid 71.30 ± 46.31 4-Hydroxyphenylacetic acid 3.32 ± 1.36 
Palmitic acid 31.34 ± 51.35 Isoleucine 3.26 ± 3.56 
Glutaric acid 24.99 ± 16.57 Malic acid 3.01 ± 2.68 
Tyrosine 20.70 ± 17.09 3-(4-Hydroxyphenyl)propionic acid 2.68 ± 2.52 
Stearic acid 20.32 ± 36.73 4-Methylvaleric acid 2.38 ± 1.34 
Succinic acid 15.65 ± 17.93 Sebacic acid 2.24 ± 2.07 
Oleic acid 15.55 ± 22.61 Proline 2.20 ± 1.16 
p-Cresol 14.77 ± 7.49 Benzoic acid 0.80 ± 0.59 
3-Hydroxyphenylacetic acid 13.09 ± 8.54 4-Hydroxybenzoic acid 0.75 ± 0.61 
Alanine 12.23 ± 8.29 Myristic acid 0.65 ± 1.62 
Methylsuccinic acid 10.77 ± 6.19 Nonanoic acid — 
aValues are means and standard deviations. 
 
Both dietary intake and physiological status affect the pH value and chemical composition of 
human fecal water. Such factors may cause interindividual variability [15]. Although this method 
has been validated in a wide range of concentrations, the data reported in the current work might 
not reflect an average profile of fecal water of healthy subjects; therefore, great care should be 
taken when studying clinical samples. 
 
CONCLUSIONS 
Fecal water is a complex mixture of varieties of metabolites with a wide range of 
physicochemical properties and boiling points. The analytical method developed here provides a 
qualitative and quantitative GC/MS, with high sensitivity and efficiency, coupled with 
derivatization of ECF in aqueous medium. The parameters affecting derivatization efficiency and 
GC chromatographic separation were discussed and optimized. The pH of extraction solvent and 
storage conditions of fecal samples were investigated based on multivariate statistical analyses 
(PCA and PLS–DA) and univariate statistical validation (Student’s t test), where deionized water 
exhibited better extraction properties. The proposed protocol was validated extensively on the 
basis of linearity, sensitivity, and repeatability of analytical equipment and the derivatization 
method. The qualitative means combining EI mass spectral database searching, CI mass spectra 
validation, and reference substance comparison identified and structurally confirmed 73 
compounds in human fecal water, suggesting a promising approach of human fecal water 
metabolome characterization. 
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